Summary
Bromocriptine has been successfully used to treat hyperprolactinaemic disorders of ovulation; treatment with 5.0 to 7.5mg daily results in normalisation of serum prolactin concentrations and restoration of ovulatory menstruation in most patients with hyperprolactinaemic amenorrhoea or oligomenorrhoea. It is equally effective in hyperprolactinaemic patients with pituitary tumours as in those with normal pituitary x-rays, but the choice of bromocriptine as primary treatment in the former group (especially in those patients who desire pregnancy) is a matter of some controversy and requires careful judgement.
Bromocriptine has also been used, with reported success, in infertility associated with luteal insufficiency, the polycystic ovary syndrome, normoprolactinaemic amenorrhoea and ovulatory infertility. However, its role in the treatment of these disorders will remain uncertain until more extensive, adequately controlled clinical trials are available.
Similar content being viewed by others
References
Abu-Fadil, S.; Devane, G.; Siler, T.M. and Yen, S.S.C.: Effects of oral contraceptive steroids on pituitary prolactin secretion. Contraception 13: 79 (1976)
Aono, T.; Miyake, A.; Shioji, T.; Kinugasa, T.; Onishi, T. and Kurachi, K.: Impaired LH release following exogenous estrogen administration in patients with amenorrhoea — galactorrhoea syndrome. Journal of Clinical Endocrinology and Metabolism 42: 696 (1976)
Bergh, T.; Nillius, S.J. and Wide, L.: Clinical course and outcome of pregnancy in amenorrhoeic women with hyperprolactinaemia and pituitary tumours. British Medical Journal 1:875 (1978)
Bertrand, G. and Tolis, G.: Surgical treatment of prolactinomas; in Tolis and Naftolin (Eds) Clinical Neuroendocrinology, in press (Raven Press, New York 1979)
Besser, G.M. and Thorner, M.O.: Bromocriptine in the treatment of hyperprolactinaemia — hypogonadism syndromes. Postgraduate Medical Journal 52 (Suppl. 1): 64 (1976)
Beumont, P.; Bruwer, J.; Pimstone, B.; Vinik, A. and Utian, W.: Bromergocryptine in the treatment of phenothiasine-induced galactorrhoea. British Journal of Psychiatry 126: 285 (1975)
Bohnet, H.G., Dahlen, H.G.; Wuttke, W. and Schneider, H.P.G.: Hyperprolactinaemic anovulatory syndrome. Journal of Clinical Endocrinology and Metabolism 42: 132 (1976)
Child, D.F.; Gordon, H.; Mashiter, K. and Joplin, G.F.: Pregnancy, prolactin and pituitary tumours. British Medical Journal 1: 604 (1975)
Corbey, R.S.; Cruysberg, J.R.M. and Rolland, R.: Visual abnormalities in pregnancy following bromocriptine medication. Obstetrics and Gynecology 50 (Suppl. 1): 695 (1977)
Corbey, R.S.; Lequin, R.M. and Rolland, R.: Hyperprolactinaemia and secondary amenorrhoea; in Crosignani and Robyn (Eds) Prolactin and Human Reproduction, p.203 (Academic Press, London, New York, San Francisco 1977)
Crosignani, P.G.; Reschini. E.; Lombroso, G.C.; Arosio, M. and Peracchi, M.: Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea. British Journal of Obstetrics and Gynaecology 85: 773 (1978)
Daughaday, W.H.: The adenohypophysis; in Williams (Ed) A Textbook of Endocrinology, p.31 (Sanders, Philadelphia 1974)
Del Pozo, E., Wyss. H.; Lancranfan. I.; Obdensky, W. and Varga, L.: In Crosignani and Mishell (Eds Ovulation in the Human, p.297 (Academic Press. London 1976)
Fluckiger, E.: Drugs and control of prolactin secretion; in Boynes and Griffiths (Eds) Prolactin and Carcinogenesis, p.162 (Alpha Omega Alpha, Cardiff 1977)
Franks, S.: Disorders of human prolactin secretion, M.D. Thesis, University of London (1977)
Franks, S.: Prolactin; in Gray and James (Ed) Hormones in Blood, p.294 (Academic Press, London 1979)
Franks, S. and Jacobs, H.S.: Characterisation and management of hyperprolactinaemic amenorrhoea; in Crosignani and Robyn (Eds) Prolactin and Human Reproduction, p.245 (Academic Press, London, New York, San Francisco 1977)
Franks, S.; Murray. MA.F.; Jequier, A.M.; Steele. S.J.; Nabarro, J.D.N. and Jacobs. H.S.: Incidence and significance of hyperprolactinaemia in women with amenorrhoea. Clinical Endocrinology 4: 597 (1975)
Franks, S.; Nabarro, J.D.N. and Jacobs, H.S.: Prevalence and presentation of hyperprolactinaemia in patients with ‘functionless’ pituitary tumours. Lancet 1: 778 (1977)a
Franks, S.; Jacobs, H.S.; Hull, M.G.R.; Steele, S.J. and Nabarro, J.D.N.: Management of hyperprolactinaemic amenorrhoea. British Journal of Obstetrics and Gynaecology 84: 241 (1977)b
Franks, S.; Jacobs. H.S.; Martin, N. and Nabarro, J.D.N.: Hyperprolactinaemia and impotence. Clinical Endocrinology 8: 277 (1978)
Friesen, H.G. and Tolis, G.: The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian co-operative study. Clinical Endocrinology 6 (Suppl): 915 (1977)
Gemzell, C.: Induction of ovulation in infertile women with pituitary tumours. American Journal of Obstetrics and Gynecology 121: 311 (1975)
Glass, M.R.; Shaw, R.W.; Williams, J.W.; Butt, W.R.; Logan-Edwards, R. and London, D.R.: Control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogens and progesterone in the LH and FSH response to LHRH. Clinical Endocrinology 5: 521 (1976)
Griffith, R.W.; Turkalj, I. and Braun, P.: Outcome of pregnancy in mothers given bromocriptine. British Journal of Clinical Pharmacy 5: 227 (1978)
Hardy, J.; Beauregard, H. and Robert. F.: Prolactin secreting pituitary adenomas: transsphenoidal microsurgical treatment; in Robyn and Harter (Ed) Progress in Prolactin Physiology and Pathology (Elsevier-North Holland, Amsterdam 1978)
Jacobs. H.S.; Franks, S.; Murray, M.A.F.; Hull, M.G.R.; Steele, S.J. and Nabarro, J.D.N.: Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clinical Endocrinology 5: 439 (1976)
Jacobs, H.S.; Knuth, U.; Hull, M.G.R. and Franks, S.: Post oral contraceptive amenorrhoea — cause or coincidence? British Medical Journal 2: 940 (1977)
Jacobs, H.S. and Wright, C.S.: Bromocriptine in obstetrics and gynecology. British Journal of Hospital Medicine. In press (1978)
Jewelewicz, R.; Zimmerman. E.A. and Carmel, P.W.: Conservative management of a pituitary tumour during pregnancy following induction of ovulation with gonadotropins. Fertility and Sterility 23: 35 (1977)
Keye, W.R.; Chang, R.J. and Jaffe, R.B.: Prolactin secreting pituitary adenomas in women with amenorrhoea or galactorrhoea. Obstetric and Gynaecological Survey 32/11: 727 (1977)
Kleinberg, D.L.; Noel, G.L. and Frantz, A.G.: Galactorrhoea: 235 cases including 48 with pituitary tumours. New England Journal of Medicine 296: 589 (1977)
Lenton, E.A.; Sobowale, O.S. and Cooke, I.D.: Prolactin concentrations in ovulatory but infertile women: treatment with bromocriptine. British Medical Journal 2: 1179 (1977)
Mornex, R.; Orgiazzi, J.; Hugues, B.; Gagnaire, J.C. and Claustrat, B.: Normal pregnancies after treatment of hyperprolactinaemia with bromoergocryptine, despite suspected pituitary tumours. Journal of Clinical Endocrinology and Metabolism 47: 290 (1978)
Pepperell, P.J.; Evans, J.H.; Brown, J.B.; Smith, M.A.; Healy, D. and Burger, H.G.: Serum prolactin levels and the value of bromocriptine in the treatment of anovulatory infertility. British Journal of Obstetrics and Gynaecology 84: 58 (1977)a
Pepperell, R.J.; McBain, J.C.; Winstone, S.M.; Smith, M.A. and Brown, J.B.: Corpus luteum function in early pregnancy following ovulation induction with bromocriptine. British Journal of Obstetrics and Gynaecology 84: 898 (1977)b
Posner, B.I.: in James(Ed) Endocrinology, Proceedings of V International Congress of Endocrinology, vol.2. p.178 (Excerpta Medica, Amsterdam 1977)
del Pozo, E.; Wyss, H.; Lancranfan, I.; Obdensky, W. and Varga, L.; in Crosignani and Mishell (Eds) Ovulation in the Human, p.297 (Academic Press, London1976)
Reichlin, S.: The Prolactinoma Problem. New England Journal of Medicine 300: 313 (1979)
Seppala, M. and Hironven, E.: Raised prolactin levels associated with hirsutism and amenorrhoea. British Medical Journal 4: 144 (1975)
Seppala, M.; Hironven, E. and Ranta, T.: Hyperprolactinaemia and luteal insufficiency. Lancet 1: 229 (1976)af
Seppala, M.; Hironven, E. and Ranta, T.: Bromocriptine treatment of secondary amenorrhoea. Lancet 1: 1154 (1976) b
Thorner, M.O. and Besser, G.M.: Hyperprolactinaemia and gonadal function: results of bromocriptine treatment; in Crosignani and Robyn (Eds) Prolactin and Human Reproduction (Academic Press, London 1977)
Thorner, M.O.; McNeilly, A.S.; Hagen, C. and Besser, G.M.: Long term treatment of galactorrhoea and hypogonadism with bromocriptine. British Medical Journal 2: 419 (1974)
Thorner, M.O., Besser, G.M.; Jones, A.; Oncie, J. and Jones, A.E.: Bromocriptine treatment of female infertility: report of 13 pregnancies. British Medical Journal 4: 694 (1975)
Tolis, G. and Franks, S.: Physiology and pathology of prolactin secretion; in Tolis(Ed) Clinical Neuroendocrinology: A Pathophysiologic Approach, in press (Raven Press, New York 1979)
Tolis, G. and Naftolin, F.: Induction of menstruation with bromocriptine in patients with euprolactinaemic amenorrhoea. American Journal of Obstetrics and Gynecology 126: 426 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Franks, S. Use of Bromocriptine in Hyperprolactinaemic Anovulation and Related Disorders. Drugs 17, 337–348 (1979). https://doi.org/10.2165/00003495-197917050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197917050-00003